Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by University of Louisville
Northwestern University
Regenerex, LLC
Duke University
Information provided by (Responsible Party):
University of Louisville Identifier:
First received: July 6, 2007
Last updated: August 17, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2031
  Estimated Primary Completion Date: March 2026 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):